← FDA Drug Approvals (Drugs@FDA)

PALIPERIDONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CSPC OUYI · Approved 2020-10-29

Drug application

FDA Application #

ANDA212807

Application type

Abbreviated New Drug Application (Generic)

Brand name

PALIPERIDONE

Generic name

PALIPERIDONE

Active ingredients

PALIPERIDONE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

CSPC OUYI

Manufacturer

Tris Pharma Inc

First approval

2020-10-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown